Company / R&D per Share
ATOSSA THERAPEUTICS, INC. R&D per Share History
FY2013-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.08
FY2016
5-year range
$0.05 / $1.08
FY2013-FY2016
Trend
+2297.7%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +2298% YoY in FY2016, a notable deviation from the 3-year average annual change of +738%.
Based on SEC 10-K filings.
1.08 in FY2016 with a 3-year CAGR of +92.1%.
Improved from $0.06 to $1.08 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +92.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, r&d per share increased 2297.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $1.08 | +2297.7% |
| FY2015 | $0.05 | -24.0% |
| FY2014 | $0.06 | -61.1% |
| FY2013 | $0.15 | - |
| FY2012 | - | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026